363 related articles for article (PubMed ID: 18576335)
21. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study.
Suzuki T; Ikari K; Yano K; Inoue E; Toyama Y; Taniguchi A; Yamanaka H; Momohara S
PLoS One; 2013; 8(4):e61045. PubMed ID: 23577190
[TBL] [Abstract][Full Text] [Related]
22.
Guzmán-Guzmán IP; Ramírez-Vélez CI; Falfán-Valencia R; Navarro-Zarza JE; Gutiérrez-Pérez IA; Zaragoza-García O; Ramírez M; Castro-Alarcón N; Parra-Rojas I
Front Immunol; 2021; 12():718246. PubMed ID: 34421923
[TBL] [Abstract][Full Text] [Related]
23. Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies.
Pérez-Pérez ME; Nieto-Torres E; Bollain-Y-Goytia JJ; Delgadillo-Ruíz L
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791230
[TBL] [Abstract][Full Text] [Related]
24. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
[TBL] [Abstract][Full Text] [Related]
25. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
Yamada R; Suzuki A; Chang X; Yamamoto K
Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
[TBL] [Abstract][Full Text] [Related]
26. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.
Burr ML; Naseem H; Hinks A; Eyre S; Gibbons LJ; Bowes J; Wilson AG; Maxwell J; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Worthington J; ; ; Barton A
Ann Rheum Dis; 2010 Apr; 69(4):666-70. PubMed ID: 19470526
[TBL] [Abstract][Full Text] [Related]
27. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
[TBL] [Abstract][Full Text] [Related]
28. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine.
Martinez-Prat L; Palterer B; Vitiello G; Parronchi P; Robinson WH; Mahler M
Expert Rev Clin Immunol; 2019 Oct; 15(10):1073-1087. PubMed ID: 31524005
[No Abstract] [Full Text] [Related]
30. Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis.
Cheng J; Zhang H; Zhuang C; Liu R
J Rheumatol; 2012 Jun; 39(6):1159-65. PubMed ID: 22505706
[TBL] [Abstract][Full Text] [Related]
31. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population.
Barton A; Bowes J; Eyre S; Spreckley K; Hinks A; John S; Worthington J
Arthritis Rheum; 2004 Apr; 50(4):1117-21. PubMed ID: 15077293
[TBL] [Abstract][Full Text] [Related]
32. The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population.
Chen R; Wei Y; Cai Q; Duan S; Ren D; Shen J; He D; Fang M; Lv K; Cheng N; Sun S
Rheumatol Int; 2011 Dec; 31(12):1631-4. PubMed ID: 20563870
[TBL] [Abstract][Full Text] [Related]
33. Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis.
Cappelli LC; Konig MF; Gelber AC; Bingham CO; Darrah E
Arthritis Res Ther; 2018 Mar; 20(1):59. PubMed ID: 29566742
[TBL] [Abstract][Full Text] [Related]
34. PADI4 polymorphisms and the functional haplotype are associated with increased rheumatoid arthritis susceptibility: A replication study in a Southern Mexican population.
Baños-Hernández CJ; Navarro-Zarza JE; Parra-Rojas I; Vázquez-Villamar M; Ramón Padilla-Gutiérrez J; Valle Y; Reyes-Castillo Z; Magdalena Torres-Carrillo N; García-Arellano S; Brennan-Bourdon LM; Muñoz-Valle JF
Hum Immunol; 2017 Sep; 78(9):553-558. PubMed ID: 28551357
[TBL] [Abstract][Full Text] [Related]
35. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis.
Takizawa Y; Sawada T; Suzuki A; Yamada R; Inoue T; Yamamoto K
Scand J Rheumatol; 2005; 34(3):212-5. PubMed ID: 16134727
[TBL] [Abstract][Full Text] [Related]
36. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
37. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity.
Halvorsen EH; Pollmann S; Gilboe IM; van der Heijde D; Landewé R; Ødegård S; Kvien TK; Molberg Ø
Ann Rheum Dis; 2008 Mar; 67(3):414-7. PubMed ID: 18006540
[TBL] [Abstract][Full Text] [Related]
38. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
Darrah E; Rosen A; Giles JT; Andrade F
Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
[TBL] [Abstract][Full Text] [Related]
40. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
